Leigh Goedeke

5PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsMetabolic medicineSeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice.

|Dec 04, 2024
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease.

Swayam Prakash Srivastava, Han Zhou, Rachel Shenoi

|Mar 03, 2022
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis.

Traci E LaMoia, Gina M Butrico, Hasini A Kalpage

|Jan 26, 2021
Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis.

Nathan L Price, Xinbo Zhang, Pablo Fernández-Tussy

|Oct 04, 2019
Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates.

Leigh Goedeke, Liang Peng, Valle Montalvo-Romeral

Pageof 1

Frequent Collaborators

4 joint publications

Gerald I Shulman

2 joint publications

Xinbo Zhang

2 joint publications

Alberto Canfrán-Duque

1 joint publications

Valle Montalvo-Romeral